Tags Archives: hemoadsorption

thumbnail
0 comment

Kinetics of Bilirubin and Ammonia Elimination during Hemadsorption Therapy in Secondary Sclerosing Cholangitis Following ECMO Therapy and Severe COVID-19

This case reports on a 61-year-old woman with confirmed COVID-19, who was admitted to a different hospital with a productive cough that she had had for a few days. [pdf-embedder..

Read More
thumbnail
0 comment

Use of Hemoadsorption in Patients With Severe Intoxication Requiring Extracorporeal Cardiopulmonary Support—A Case Series

Abstract Drugs intoxications often lead to severe vasoplegia and cardiogenic shock, and VA-ECMO represents a viable therapy option. However, as cardiopulmonary support is not contributing to the removal of the..

Read More
thumbnail
0 comment

The Potential Role of Extracorporeal Cytokine Removal in Hemodynamic Stabilization in Hyperinflammatory Shock

Abstract Hemodynamic instability due to dysregulated host response is a life-threatening condition requiring vasopressors and vital organ support. Hemoadsorption with Cytosorb has proven to be effective in reducing cytokines and..

Read More
thumbnail
0 comment

Hemoadsorption with CytoSorb® and the early course of linezolid plasma concentration during septic shock

This case reports on a 61-year-old woman with Ulrich Turner syndrome, who developed septic shock following right hemicolectomy. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/06/CoW_25_2021_E_web_compressed.pdf"]  

Read More
thumbnail
0 comment

The effect of hemoadsorption on rivaroxaban blood plasma concentration in emergency cardiac surgery

Abstract Hemoadsorption was used in a 59-year-old patient with an acute type A aortic dissection, who was on rivaroxaban and dual antiplatelet therapy with clopidogrel and acetylsalicylic acid. Our aim..

Read More
thumbnail
0 comment

Hemoadsorption eliminates remdesivir from the circulation: Implications for the treatment of COVID‐19

Abstract Both antiviral treatment with remdesivir and hemoadsorption using a CytoSorb® adsorption device are applied in the treatment of severe COVID‐19. The CytoSorb® adsorber consists of porous polymer beads that adsorb a..

Read More
thumbnail
0 comment

Hemoadsorption with CytoSorb in Septic Shock Reduces Catecholamine Requirements and In-Hospital Mortality: A Single-Center Retrospective ‘Genetic’ Matched Analysis

Abstract Septic shock is a major burden to healthcare with mortality rates remaining high. Blood purification techniques aim to reduce cytokine levels and resultant organ failure. Regarding septic shock, hemoadsorption..

Read More
thumbnail
0 comment

Hemoadsorption during Cardiopulmonary Bypass in Patients with Endocarditis Undergoing Valve Surgery: A Retrospective Single-Center Study

Abstract Background: Aim of this study was to evaluate the outcomes of endocarditis patients undergoing valve surgery with the Cytosorb® hemoadsorption (HA) device during cardiopulmonary bypass. Methods: From 2009 until 2019,..

Read More
thumbnail
0 comment

Hemoadsorption to treat severe iatrogenic intoxication to Patent Blue: A Case Report

This case reports on a 27-year-old woman (body weight 45 kgs), who was admitted to the Emergency Department of a peripheral hospital in Brussels due to intoxication of unknown origin...

Read More
thumbnail
0 comment

Hemoadsorption Treatment of Patients with Acute Infective Endocarditis during Surgery with Cardiopulmonary Bypass – A Case Series

Abstract Introducton: Infective endocarditis is a serious disease condition. Depending on the causative microorganism and clinical symptoms, cardiac surgery and valve replacement may be needed, posing additional risks to patients..

Read More
thumbnail
0 comment

Treatment of post-cardiopulmonary bypass SIRS by hemoadsorption: a case series

Abstract The use of cardiopulmonary bypass (CPB) in cardiothoracic surgery results in a well-known activation of the immunologic response. In some cases, however, this triggered immunologic response may be excessive,..

Read More